Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2009Expert Review of Cardiovascular Therapy

Pharmacological therapies such as doxycycline, roxithromycin, and statins show promise in limiting abdominal aortic aneurysm growth, but large randomized trials are required to confirm efficacy.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does pharmacological therapy reduce the growth of abdominal aortic aneurysms in patients with AAA?

Population

Patients with abdominal aortic aneurysm (AAA)

Design

Review

Key result

Pharmacological therapies such as doxycycline, roxithromycin, and statins show promise in limiting abdominal aortic aneurysm growth, but large randomized trials are required to confirm efficacy.

Authors

AAAhmed N Assar

Discussion

Loading...

Member takes

Overview

Current evidence insufficient to guide AAA pharmacotherapy; leaves open efficacy of doxycycline, roxithromycin, and statins pending large RCTs.

Structured PICO

Does pharmacological therapy reduce the growth of abdominal aortic aneurysms in patients with AAA?

P
Population
Patients with abdominal aortic aneurysm (AAA)
I
Intervention
Pharmacological therapy (including doxycycline, roxithromycin, statins) and cardiovascular risk factor control (smoking cessation)
O
Outcome
AAA growth and aneurysm-related mortality

While surgical repair is standard for large AAAs, pharmacological therapies and smoking cessation show promise for limiting the growth of small aneurysms, pending validation in large randomized trials.

Limitations

  • Randomized trials with large numbers of patients and long follow-ups are required for the thorough investigation of safe and effective medical therapies
  • Requires randomized trials with large numbers of patients and long follow-ups

Cite This Study

Ahmed N Assar (2009) conducted a review in Abdominal aortic aneurysm. Pharmacological therapy (doxycycline, roxithromycin, statins) was evaluated. Pharmacological therapies such as doxycycline, roxithromycin, and statins show promise in limiting abdominal aortic aneurysm growth, but large randomized trials are required to confirm efficacy.

synapsesocial.com/papers/6a99b7b875d50b594933a4e4https://doi.org/10.1586/erc.09.56
View Full Paper
Ask AI
Bookmark
Share